Calliditas is a specialty pharmaceutical company developing high value products for patients with significant unmet medical needs. With a highly experienced, dynamic management team, Calliditas draws on its extensive experience of pharmaceutical development and marketing to efficiently identify and progress valuable and de-risked products.

US Human Resources Manager

Calliditas Therapeutics

Rare Disease Account Manager

Cardiovascular Sales Specialist

Transplant Account Specialist

Executive Renal Sales Specialist

Executive Hyperkalemia Hospital Sales Specialist

Intern CV Metaboloc Cardiology Hospital Sales District Manager

Cardiovascular Hosptial  Specialty Representative

Pharmaceutical Sales Specialist Overlay

Professional Sales Specialist

Territory Manager

Direct Sales Representative

Sr. Regional Business Manager

Sales Specialist

Medical Sales Representative

District Sales Manager

Territory Sales Manager

Rare Disease Account Manager (Nephrology)/ National Field Sales Trainer

Rare Disease Account Manager (Nephrology)

Medical Account Manager (Medical Device/ Biotechnology

Regional Business Manager (Rare Disease)

Senior Specialty Sales Representative

Mosaic: Co-founder, Director (foster care/adoption resourcing/awareness/

Tier II Pharmaceutical Sales Representative- Cardiovascular and Diabetes

Manager in Training/ Sales Rep.

Advertising Sales Representative

Teacher

Field Medical Director

Per Diem Pharmacist, Emergency Medicine

Residency Director, PGY2 Emergency Medicine

Clinical Pharmacy Specialist

Medical Science Liaison, Renal/Cardio

Director Global Health Sciences (Medical Science Liaison)

Clinical Pharmacist - Transplant Intensive Care

President North America

Board Member

Chief Commercial Officer (CCO)

Senior Vice President, General Manager US

VP General Manager & Head of US Commercial

VP Global Therapeutic Area Head Rare Diseases

Product Specialist/Sales Representative

Associate Medical Science Liaison

Lead Pharmacist - Cardiology

Clinical Pharmacist

PGY1 Pharmacy Resident

Pharmacology Tutor

Community Pharmacy Intern

Inpatient Pharmacy Intern

Lab Teaching Assistant

Cloudflare DNS

Outlook

Microsoft Office 365

CloudFlare Hosting

WordPress.org

Linkedin Marketing Solutions

Corporate OverviewLexicon Pharmaceuticals is a biopharmaceutical company that has harnessed the power of genetics for drug discovery.  Our research team has generated a pipeline of novel drug candidates in clinical development across a broad range of indications.The Genome: Our Source of DiscoveryWe have applied  gene knockout technology to thousands of potential drug targets encoded in the human genome. Our scientists have gained a thorough understanding of target biology and identified new points of intervention for future therapies.  We have integrated a series of recombinant DNA and chemistry technologies into a systematic drug discovery and development process. Our unique knowledge of targets from the human genome has allowed us to better evaluate and advance novel drug candidates with great promise for patients.A Diverse Pipeline of Targeted TherapiesOur genomics-based approach to drug discovery has enabled our scientists to select drug targets across a broad range of indications with high unmet medical need. All of our drug candidates are new molecular entities discovered internally by our dedicated drug discovery teams and designed to affect particular points on a genetically-defined pathway that can be used to fight a disease process. We have advanced new therapies across a wide spectrum of human disease, from conditions affecting millions of people, such as diabetes, to carcinoid syndrome, an orphan cancer indication with few treatment options.

Cardiovascular Sales Specialist - Greenville, NC

Associate Director, Type 1 Diabetes Marketing

Senior Director/Director Type 1 Diabetes Marketing

Lexicon Pharmaceuticals, Inc.

Amazon CloudFront

Salesforce

Route 53

Rackspace MailGun

Mimecast

CareDx: Transforming Transplant Patient Care Through Novel Surveillance Management SolutionsCareDx, Inc. is dedicated to improving the lives of organ transplant patients through non-invasive diagnostics. By combining the latest advances in genomics and bioinformatics technology, with a commitment to generating high quality clinical evidence through trials and registries, CareDx is at the forefront of organ transplant surveillance and pre-transplant HLA typing solutions.NASDAQ:CDNAAbout AlloSure®AlloSure is the first and only non-invasive blood test that directly measures allograft injury and identifies the probability of active rejection to better manage kidney transplant patients. AlloSure is a clinical-grade, proprietary Next-Generation Sequencing (NGS) based test to detect donor-derived cell-free DNA (dd-cfDNA) in order to identify organ injury in kidney transplant recipients. AlloSure is analytically validated as a sensitive, specific, and precise measurement of dd-cfDNA. AlloSure detects active rejection (acute active ABMR, chronic active ABMR, or TCMR) with high accuracy, outperforms serum creatinine in kidney transplant recipients, and is highly sensitive in distinguishing ABMR from no ABMR. AlloSure is performed in the CareDx CLIA-certified laboratory. http://www.allosure.com/About AlloMap® AlloMap Molecular Expression Testing is a non-invasive blood test used to aid in the identification of heart transplant recipients with stable allograft function who have a low probability of moderate/severe acute cellular rejection at the time of testing in conjunction with standard clinical assessment. AlloMap testing measures the expression levels of 20 genes from a blood sample. The combined expression of these genes is represented as an AlloMap test score. AlloMap is performed in the CareDx CLIA-certified laboratory and has been commercially available in the United States since 2005. AlloMap was cleared by the U.S. Food and Drug Administration in 2008 and was CE marked for the European Union in 2011. Use of AlloMap is also included in the International Society for Heart and Lung Transplantation (ISHLT) Practice Guidelines, published in August 2010, the worldwide standard for the care of heart transplant patients.http://www.allomap.com/

Transplant Account Manager - Remote

Assoc. Director/Director, Business Development

EMR Project Manager

CareDx, Inc.

ServiceNow

Pardot

MailChimp SPF

Zendesk

We're transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet. For more information, visit www.astrazeneca.com.Community Guidelines: bit.ly/2MgAcio

GP Sales Representative - Northern Territory

Senior Scientist Bioscience Immunology, Early Respiratory And Immunology

Associate Principal Scientist, Early Respiratory and Immunology

Real World Evidence-Associate Director

AstraZeneca

Mailchimp Mandrill

Amazon AWS

AT&T is a Texas-based telecommunication company that offers services such as mobile telephony and internet connectivity for residential and commercial sectors.

Brian Mercke

Rare Disease Account Manager at Calliditas Therapeutics

Brian Mercke's Professional Contact Details

Brian Mercke's Current Company Details

Calliditas Therapeutics

Brian Mercke's Work History and Education

Others Named Brian Mercke

Frequently Asked Questions about Brian Mercke

What company does Brian Mercke work for?

What is Brian Mercke's role at Calliditas Therapeutics?

What is Brian Mercke's email address?

What is Brian Mercke's business email address?

What is Brian Mercke's HQ phone number?

What industry does Brian Mercke work in?

Who are Brian Mercke's colleagues?

Colleagues at Calliditas Therapeutics

Prospect on LinkedIn

People Search

Company Search

Erik Straub

Michael Transon

Ready to try it out?